Skip to content
PoliTrackerPrototype - alpha version 0.1
← Policies

Proposed

Bill · 119th Congress · HR 10212

PEPTIDES for Veterans Act

Refreshed 3 h ago

Introduced 2026-09-01Topic: veterans military · health care

Summary

AI-generated summary, report an error

This bill directs the Secretary of Veterans Affairs to review federal regulations and guidance about peptides and to set definitions of "peptide" and "peptide-based therapy," with a report to Congress within 180 days. After that report, the VA must study the safety, effectiveness, and possible benefits of peptide-based therapies for veterans treated at VA medical facilities, finishing within 18 months. The study report must say whether these therapies should be offered to veterans. If the VA decides they should, it must run a voluntary pilot program offering the therapies for up to 5 years and report the results to Congress.

Full text and official record on Congress.gov

Sponsors

Action history

DateChamberActionStatus effect
2026-09-08HouseReferred to the Subcommittee on Health.refer
2026-09-01HouseReferred to the House Committee on Veterans' Affairs.refer
2026-09-01Introduced in Houseintroduce
2026-09-01Introduced in Houseintroduce
Source: GovInfo Bill Status (Library of Congress), fetched 2026-09-24. Provisions and opinion polling arrive in a later release.